openPR Logo
Press release

Reporter Gene Assays Market| Key Players : Thermo Fisher Scientific , Bio-Rad Laboratories , Merck , PerkinElmer , Promega Corporation , Biotium , Abcam plc,Danaher Corporation,Geno Technology ,Genecopoeia, Inc., InvivoGen and PromoCell.

03-28-2019 04:31 PM CET | Health & Medicine

Press release from: MarketsandMarkets.com

Reporter Gene Assays Market| Key Players : Thermo Fisher

According to the new market research report "Reporter Gene Assay Market by Reagents & Assay kits (Luciferase, Green Fluorescent Protein, â-glucuronidase, â-galactosidase), Application (Gene Regulation, Protein Interaction, Cell Signalling Pathways), End Users, Region - Global Forecast to 2024", published by MarketsandMarkets™, the Reporter Gene Assays Market is expected to reach USD 2.6 billion by 2024 from an estimated USD 1.6 billion in 2019, at a CAGR of 10.1%.

Don't miss out on business opportunities in Reporter Gene Assays Market,
Speak To our Analyst:- https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=20053198&utm_source=OpenPR&utm_medium=Paid

The major factors driving the growth of this market include increasing funding for cell-based research, growing applications of gene expression, and a rising preference for cell-based assays.

By product, the Assay kits segment to dominate the Reporter Gene Assays Market in 2019

On the basis of product, the market is broadly split into reagents and assay kits. The assay kits segment is expected to account for the larger share of the Reporter Gene Assays Market in 2019. The large share of the assay kits segment can be attributed to their repeated use in gene expression studies and signaling pathway analysis during gene transcription or translation levels. Assay kits are preferred over standalone reagents in cases where a validated protocol for assay development is available. Assay kits not only save time but also offer technological advantages, easy availability, and greater convenience.

Browse in-depth TOC on "Reporter Gene Assays Market"

96 – Tables

32 – Figures

160 – Pages

Get 10% Free Customization on this Report:

https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=20053198&utm_source=OpenPR&utm_medium=Paid

By application, the cell signaling pathways segment is expected to grow at the highest CAGR during the forecast period (2019-2024)

Based on application, the Reporter Gene Assays Market is segmented into gene regulation, protein interaction, cell signaling pathways, and promotor structural & functional analysis. In 2019, the cell signaling pathways segment is expected to grow at the highest CAGR during the forecast period. The high growth rate of this segment is attributed to its importance in several cellular functionalities (such as cell differentiation, cell fate determination, and cell growth) and advanced applications of cell signaling in life science sectors (such as biotechnology, molecular biology, and microbiology).

North America to hold the largest regional market share in 2019

North America is expected to account for the largest share of the Reporter Gene Assays Market in 2019, followed by Europe. The large share of North America in the global market can be attributed to the growing academic and government investments in genomics and proteomics research; rising demand for cell-based assays in research; increasing focus on cell-based therapeutics; and rising focus of stakeholders on research projects involving proteins, associated biomolecules, and genes.

Inquiry Before Buying:
https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=20053198&utm_source=OpenPR&utm_medium=Paid

The prominent players in the Reporter Gene Assays Market are Thermo Fisher Scientific (US), Bio-Rad Laboratories (US), Merck (Germany), PerkinElmer (US), Promega Corporation (US), Biotium (US), Abcam plc (UK), Danaher Corporation (US), Geno Technology (US), Genecopoeia, Inc. (US), InvivoGen (France), PromoCell (Germany), Becton, Dickinson and Company (US), Biotium, Inc. (US), Canvax (Spain), LI-COR, Inc. (US), System Biosciences, LLC (US), Indigo Biosciences, Inc. (US), BioThema (Sweden), Takara Bio Inc (US), BioAssay Systems (US), Cell Biolabs, Inc. (US), BPS Bioscience, Inc (US), Biosynth AG (Switzerland), and Cayman Chemical (US).

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets's flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Reporter Gene Assays Market| Key Players : Thermo Fisher Scientific , Bio-Rad Laboratories , Merck , PerkinElmer , Promega Corporation , Biotium , Abcam plc,Danaher Corporation,Geno Technology ,Genecopoeia, Inc., InvivoGen and PromoCell. here

News-ID: 1677456 • Views:

More Releases from MarketsandMarkets.com

Medical Robots Market Worth $33.8 billion | MarketsandMarkets™
Medical Robots Market Worth $33.8 billion | MarketsandMarkets™
Medical Robots Market in terms of revenue was estimated to be worth $16.0 billion in 2024 and is poised to reach $33.8 billion by 2029, growing at a CAGR of 16.1% from 2024 to 2029 according to a new report by MarketsandMarkets™. The growth in the medical robots market is driven by the aging population and rising chronic diseases, improving reimbursement scenario, and subsequent advancements in healthcare funding & infrastructure.
Concrete Surface Retarders Market worth $89.4 million by 2023 : Major Players are Sika (Switzerland), BASF (Germany), MAPEI (Italy), GCP Applied Technologies (US), CEMEX (Mexico), W. R. Meadows (US)
Concrete Surface Retarders Market worth $89.4 million by 2023 : Major Players ar …
The report "Concrete Surface Retarders Market by Raw Material (Organic Agents and Inorganic Agents), Type (Water-based and Solvent-based), Application (Residential and Commercial), and Region (North America, Europe, Asia Pacific) - Global Forecast to 2023", The concrete surface retarders market is projected to grow from USD 72.7 million in 2018 to USD 89.4 million by 2023, at a CAGR of 4.2% between 2018 and 2023. Increase in urban population, demand for
Precast Concrete Market worth $174.1 billion by 2025 | Major Players are Lafarge …
The report "Precast Concrete Market by Element (Columns & Beams, Floors & Roofs, Girders, Walls & Barriers, Utility Vaults, Pipes, Paving Slabs), Construction Type, End-use Sector (Residential, Non-residential) - Global Forecast to 2025" The global precast concrete market size is projected to grow from USD 130.6 billion in 2020 to USD 174.1 billion by 2025, at a CAGR of 5.9% from 2020 to 2025. The market is projected to grow
Fire Stopping Materials Market worth $2.4 billion by 2026 : Major Players are Hi …
The report "Fire Stopping Materials Market by Type (Sealants, Mortar, Boards, Putty &Putty Pads, Cast-in Devices), by Application (Electrical, Mechanical, Plumbing), End-Use (Commercial, Industrial & Residential), and Region - Global Forecast to 2026" MarketsandMarkets: The fire stopping materials market is projected to reach USD 2.4 billion by 2026, at a CAGR of 11.6% from USD 1.4 billion in 2021. Fire stopping is a fire protection system for sealings of any

All 5 Releases


More Releases for Assay

Creatinine Assay Kits Market
The global creatinine assay kits market is expected to reach USD 285.86 Million by 2025, from USD 192.07 Million in 2017 growing at a CAGR of 5.1% during the forecast period of 2018 to 2025. The upcoming market report contains data for historic years 2017, the base year of calculation is 2017 and the forecast period is 2018 to 2025. Get Exclusive Sample Copy of This Report Here https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-creatinine-assay-kits-market Some of the
Lateral Flow Assay Market
Worldwide Lateral Flow Assay Market Analysis to 2027 is a specialized and in-depth study of the Lateral Flow Assay industry with a focus on the global market trend. The report aims to provide an overview of global Lateral Flow Assay market with detailed market segmentation by product & services /application and geography. Get Sample PDF at https://www.theinsightpartners.com/sample/TIPRE00005544/?utm_source=OpenPR&utm_medium=Sumaiya Lateral flow tests, also known as lateral flow immunochromatographic assays. The lateral flow assay
Transcreener® GDP GTPase Assay - The Only Mix-and-Read Fluorescent GTPase Assay …
The Transcreener GDP GTPase assay is a homogenous, fluorescent immunoassay that monitors the activity of GTPases along with GEF and GAP partners. The assay directly measures the amount of GDP produced in an in vitro GTPase reaction. BellBrook Labs' Transcreener GDP GTPase assays are available with fluorescence polarization (FP), fluorescence intensity (FI), and far-red, time-resolved Forster-resonance-energy-transfer (TR-FRET) readouts that provide a safe, HTS-compatible alternative to cumbersome radioassay methods and are more
High Throughput Flow Assay Trends 2017
ReportsWorldwide has announced the addition of a new report High Throughput Flow Assay Trends 2017 to its growing collection of premium market research reports. This market report summarizes the results of HTStec's industry-wide global web-based benchmarking survey on high throughput flow cytometry (HT flow) screening carried out in January 2017. The survey was initiated by HTStec as part of its tracking of emerging life science marketplaces and to update HTStec's previous HT
n Vitro Toxicology Market - By Method (Ex Vivo, Biochemical Assay, Cellular Assa …
Scientific analysis of the effects of toxic chemical substances on mammalian cells is called in vitro toxicology testing. It is employed in identification of hazardous chemicals and to confirm the lack of toxic properties in the early stages of the development new substances. In vitro toxicology testing is considered by key government agencies such as FDA and EPA in order to assess human risks. Rising opposition to animal testing, technological
ELISA Assay Dispensing Trends 2016
ReportsWorldwide has announced the addition of a new report ELISA Assay Dispensing Trends 2016 to its growing collection of premium market research reports. This market report summarizes the results of HTStec's industry-wide global web-based benchmarking survey on enzyme-linked immunosorbent assays (ELISA) carried out in April 2016. The survey was initiated by HTStec as part of its tracking of life science marketplaces and to update HTStec's previous ELISA Assay Trends report (June 2012).